Washington Trust Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Washington Trust Bank's BIIB Position: Q3 2019 in Review
Washington Trust Bank sold out of Biogen (BIIB) in Q3 2019, closing a stake of 965 shares — an estimated $226K sold.
Washington Trust Bank first reported a position in BIIB in Q1 2014 and held it in 22 quarters. The position peaked at $807K in Q4 2017. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.
- Washington Trust Bank reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
- Washington Trust Bank sold 965 Biogen shares in Q3 2019, an estimated $226K.
- Washington Trust Bank first reported a position in Biogen in Q1 2014 and held it in 22 quarters.
- Washington Trust Bank's Biogen position peaked at $807K in Q4 2017.
- 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.
Based on Washington Trust Bank's 13F filing for Q3 2019, filed 29 Oct 2019.